A Study to Evaluate the Effect of Deucravacitinib on Quality of Life in Participants With Plaque Psoriasis in a Community Setting

NCT05701995 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: Deucravacitinib
OTHER: Placebo

Sponsor

Bristol-Myers Squibb